blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3656854

EP3656854 - VIRUS FOR TREATING TUMORS [Right-click to bookmark this link]
StatusExamination is in progress
Status updated on  08.03.2024
Database last updated on 03.09.2024
FormerRequest for examination was made
Status updated on  24.04.2020
FormerThe international publication has been made
Status updated on  26.01.2019
Most recent event   Tooltip31.07.2024New entry: Renewal fee paid 
Applicant(s)For all designated states
Xiamen University
No. 422, Siming Nan Road
Siming District
Xiamen, Fujian 361005 / CN
For all designated states
Yang Sheng Tang Company, Ltd.
Room 205, No.17 Lundu Road
Shuangpu Town, Xihu District, Hangzhou
Zhejiang / CN
[2020/22]
Inventor(s)01 / CHENG, Tong
No.422 Si Ming Nan Road
Siming District
Xiamen Fujian 361005 / CN
02 / WANG, Wei
No.422 Si Ming Nan Road
Siming District
Xiamen Fujian 361005 / CN
03 / WAN, Junkai
No.422 Si Ming Nan Road
Siming District
Xiamen Fujian 361005 / CN
04 / FU, Wenkun
No.422 Si Ming Nan Road
Siming District
Xiamen Fujian 361005 / CN
05 / YE, Xiangzhong
No. 31 Kexueyuan Road
Changping District
Beijing 102206 / CN
06 / ZHANG, Jun
No.422 Si Ming Nan Road
Siming District
Xiamen Fujian 361005 / CN
07 / XIA, Ningshao
No.422 Si Ming Nan Road
Siming District
Xiamen Fujian 361005 / CN
 [2020/22]
Representative(s)Meissner Bolte Partnerschaft mbB
Patentanwälte Rechtsanwälte
Postfach 86 06 24
81633 München / DE
[N/P]
Former [2020/22]Held, Stephan
Meissner Bolte Patentanwälte
Rechtsanwälte Partnerschaft mbB
Postfach 86 06 24
81633 München / DE
Application number, filing date18835927.718.07.2018
[2020/22]
WO2018CN96100
Priority number, dateCN20171060073221.07.2017         Original published format: CN201710600732
[2020/22]
Filing languageZH
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2019015601
Date:24.01.2019
Language:ZH
[2019/04]
Type: A1 Application with search report 
No.:EP3656854
Date:27.05.2020
Language:EN
[2020/22]
Search report(s)International search report - published on:CN24.01.2019
(Supplementary) European search report - dispatched on:EP29.03.2021
ClassificationIPC:C12N7/00, C12N15/11, A61K35/76, A61P35/00, A61K35/768
[2021/17]
CPC:
A61K35/768 (EP,US); C12N7/00 (EP,CN,KR,US); A61K35/765 (CN,KR);
A61K35/76 (KR); A61K48/00 (EP,KR,US); A61K48/005 (CN,KR);
A61P35/00 (EP,KR,US); C12N15/11 (EP,KR); C12N15/86 (US);
C07K14/535 (US); C07K16/2818 (US); C07K2317/622 (US);
C12N15/113 (US); C12N2310/141 (US); C12N2770/32321 (EP,CN,US);
C12N2770/32332 (EP,US); C12N2770/32333 (KR); C12N2770/32343 (US);
C12N2770/32371 (US); Y02A50/30 (EP) (-)
Former IPC [2020/22]C12N7/00, C12N15/11, A61K35/76, A61P35/00
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2020/22]
TitleGerman:VIRUS ZUR BEHANDLUNG VON TUMOREN[2020/22]
English:VIRUS FOR TREATING TUMORS[2020/22]
French:VIRUS DE TRAITEMENT DE TUMEURS[2020/22]
Entry into regional phase13.02.2020Translation filed 
13.02.2020National basic fee paid 
13.02.2020Search fee paid 
13.02.2020Designation fee(s) paid 
13.02.2020Examination fee paid 
Examination procedure13.02.2020Examination requested  [2020/22]
19.10.2021Amendment by applicant (claims and/or description)
13.03.2024Despatch of a communication from the examining division (Time limit: M04)
12.07.2024Reply to a communication from the examining division
Fees paidRenewal fee
13.02.2020Renewal fee patent year 03
30.07.2021Renewal fee patent year 04
29.07.2022Renewal fee patent year 05
27.07.2023Renewal fee patent year 06
31.07.2024Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[Y]WO2015007788  (SIA LATIMA [LV]) [Y] 1-14 * abstract *;
 [Y]WO2016044656  (ANSUN BIOPHARMA INC [US]) [Y] 1-14 * abstract * * example 4; table 2 *;
 [X]US2016312314  (STORCH GREGORY A [US], et al) [X] 10,13-15 * abstract *;
 [X]  - Zhang Tie Gang ET AL, "The Genomic Characterization of Enterovirus D68 from 2011 to 2015 in Beijing, China", Biomedical and environmental sciences, Netherlands, doi:10.3967/bes2016.089, (20160901), pages 675 - 677, URL: https://pubmed.ncbi.nlm.nih.gov/27806749/, (20210315), XP055785724 [X] 10,14,15 * abstract * * page 677, paragraph 2; table 1 *

DOI:   http://dx.doi.org/10.3967/bes2016.089
 [Y]  - CHUMAKOV P M ET AL, "Oncolytic enteroviruses", MOLECULAR BIOLOGY, KLUWER ACADEMIC PUBLISHERS-PLENUM PUBLISHERS, NE, (20121009), vol. 46, no. 5, doi:10.1134/S0026893312050032, ISSN 1608-3245, pages 639 - 650, XP035122625 [Y] 1-14 * abstract * * page 641, column 2, paragraph 2 - paragraph 4 * * page 644, column 2, paragraph 4 *

DOI:   http://dx.doi.org/10.1134/S0026893312050032
 [A]  - EMILY JANE BEK ET AL, "The Pathogenesis and Prevention of Encephalitis due to Human Enterovirus 71", CURRENT INFECTIOUS DISEASE REPORTS, CURRENT SCIENCE INC, NEW YORK, (20120526), vol. 14, no. 4, doi:10.1007/S11908-012-0267-3, ISSN 1534-3146, pages 397 - 407, XP035079523 [A] 1-14 * abstract * * page 403, column 1, paragraph 4 *

DOI:   http://dx.doi.org/10.1007/s11908-012-0267-3
 [A]  - HUANG YUAN-PIN ET AL, "Molecular and epidemiological study of enterovirus D68 in Taiwan", JOURNAL OF MICROBIOLOGY, IMMUNOLOGY AND INFECTION, ELSEVIER, AMSTERDAM, NL, (20150918), vol. 50, no. 4, doi:10.1016/J.JMII.2015.07.015, ISSN 1684-1182, pages 411 - 417, XP085167237 [A] 1-14 * abstract *

DOI:   http://dx.doi.org/10.1016/j.jmii.2015.07.015
International search[Y]CN105518128  (SIA LATIMA) [Y] 1-11, 14 (all in part) * see abstract, and claims 1-14 *;
 [A]US2016355897  (NIX WILLIAM ALLAN [US], et al) [A] 1-12, 14 (all in part)* see entire document *;
 [XY]  - GenBank, (20141201), Database accession no. KM851225, XP055567901 [X] 12 (in part) * ), see sequence and related information thereof), see sequence and related information thereof * [Y] 1-11, 14 (all in part)
by applicantWO2008103755
 US2016143969
    - DOBRIKOVA et al., Mol Ther, (20080000), vol. 16, no. 11, pages 1865 - 1872
    - AU et al., Virol J, (20110000), vol. 8, page 22
    - SHAFREN et al., Int J Cancer, (20050000), vol. 115, no. 2, pages 320 - 328
    - HALEY et al., J Mol Med (Berl, (20090000), vol. 87, no. 4, pages 385 - 399
    - SCHIEBLE et al., Am J Epidemiol, (19670000), vol. 85, no. 2, pages 297 - 310
    - MERRILLGROMEIER, J Virol, (20060000), vol. 80, no. 14, pages 6936 - 6942
    - NEPLIOUEVA et al., PLoS One, (20100000), vol. 5, no. 7, page e11710
    - DOBRIKOV et al., Mol Cell Biol, (20110000), vol. 31, no. 14, pages 2947 - 2959
    - DOBRIKOV et al., Mol Cell Biol, (20130000), vol. 33, no. 5, pages 937 - 946
    - BAOHONG ZHANG et al., Developmental Biology, (20070201), vol. 302, no. 1, pages 1 - 12
    - HOU WHYANG LSLI SX et al., Virus Res, (20150000), vol. 210, pages 165 - 168
    - YIN H et al., Nat Rev Genet., (20140800), vol. 15, no. 8, pages 541 - 55
    - RILEY MKVERMERRIS W, Nanomaterials (Basel, (20170428), vol. 7, no. 5, page E94
    - "GenBank", Database accession no. X02316.1
    - RUIZ AJRUSSELL S J., MicroRNAs and oncolytic viruses. [J]. Curr Opin Virol, (20150000), vol. 13, pages 40 - 48
    - ARDOLINO MHSU JRAULET D H, "Cytokine treatment in cancer immunotherapy [J", Oncotarget, (20150000), vol. 6, no. 23, pages 19346 - 19347
    - CANDOLFI MKING GDMUHAMMAD AG et al., "Evaluation of proapototic transgenes to use in combination with Flt3L in an immune-stimulatory gene therapy approach for Glioblastoma multiforme (GBM) [J", FASEB J, (20080000), vol. 22
    - NOLAN ESAVAS PPOLICHENI AN et al., "Combined immune checkpoint blockade as a therapeutic strategy for BRCAl-mutated breast cancer [J", Science Trans Med, (20170000), vol. 9, page eaal 4922
    - ROSCA EVKOSKIMAKI JERIVERA CG et al., "Anti-angiogenic peptides for cancer therapeutics [J", Curr Pharm Biotechnol, (20110000), vol. 12, no. 8, pages 1101 - 1116
    - BIRD et al., Science, (19880000), vol. 242, pages 423 - 426
    - HUSTON et al., Proc. Natl. Acad. Sci. USA, (19880000), vol. 85, pages 5879 - 5883
    - PLUCKTHUNROSEBURGMOORE, The Pharmacology of Monoclonal Antibodies, Springer-Verlag, (19940000), vol. 113, pages 269 - 315
    - NEEDLEMAN et al., J. Mol. Biol., (19700000), vol. 48, pages 444 - 453
    - E. MEYERSW. MILLER, Comput. Appl. Biosci., (19880000), vol. 4, pages 11 - 17
    - PIRALLA et al., J Clin Microbiol, (20150000), vol. 53, no. 5, pages 1725 - 1726
    - YANG et al., Clin Vaccine Immunol, (20140000), vol. 21, no. 3, pages 312 - 320
    - HOU et al., J Virol Methods, (20150000), vol. 215-216, pages 56 - 60
    - HADAC E MKELLY E JRUSSELL S J, Mol Ther, (20110000), vol. 19, no. 6, pages 1041 - 1047
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.